Concise review: emerging role of CD44 in cancer stem cells: a promising biomarker and therapeutic target

Y Yan, X Zuo, D Wei - Stem cells translational medicine, 2015 - academic.oup.com
The reception and integration of the plethora of signals a cell receives from its
microenvironment determines the cell's fate. CD44 functions as a receptor for hyaluronan …

Emerging roles of hyaluronic acid bioscaffolds in tissue engineering and regenerative medicine

M Hemshekhar, RM Thushara… - International Journal of …, 2016 - Elsevier
Hyaluronic acid (HA), is a glycosaminoglycan comprised of repeating disaccharide units of
N-acetyl-d-glucosamine and d-glucuronic acid. HA is synthesized by hyaluronan synthases …

Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer

E Karousou, S Misra, S Ghatak, K Dobra, M Götte… - Matrix Biology, 2017 - Elsevier
Synthesis, deposition, and interactions of hyaluronan (HA) with its cellular receptor CD44
are crucial events that regulate the onset and progression of tumors. The intracellular …

Novel delivery approaches for cancer therapeutics

AK Mitra, V Agrahari, A Mandal, K Cholkar… - Journal of controlled …, 2015 - Elsevier
Currently, a majority of cancer treatment strategies are based on the removal of tumor mass
mainly by surgery. Chemical and physical treatments such as chemo-and radiotherapies …

Recent advances in pH/enzyme-responsive polysaccharide-small-molecule drug conjugates as nanotherapeutics

YF Abbasi, H Bera, D Cun, M Yang - Carbohydrate polymers, 2023 - Elsevier
Now-a-days, the polysaccharides are extensively employed for the delivery of small-
molecule drugs ascribed to their excellent biocompatibility, biodegradability and …

Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice

S Bastaki, S Aravindhan, NA Saheb, MA Kashani… - Life Sciences, 2021 - Elsevier
Immunotherapy methods using potential tumor microenvironment modulators have elicited
durable therapeutic responses in cancer treatment. Immune checkpoint molecule …

Dual-targeted nanomedicines for enhanced tumor treatment

Y Zhu, J Feijen, Z Zhong - Nano Today, 2018 - Elsevier
Based on the overexpression of specific receptors on tumor cells, active targeting
nanomedicines have been developed with the ability to efficiently deliver imaging agents in …

Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation

S Adityan, M Tran, C Bhavsar, SY Wu - Journal of controlled release, 2020 - Elsevier
Nanoparticles (NPs) that permit active targeting promise to play a key role in cancer therapy
moving forward. However, in order to successfully advance into clinic, these delivery …

Breast cancer stem cells

JS Crabtree, L Miele - Biomedicines, 2018 - mdpi.com
Breast cancer stem cells (BCSC) have been implicated in tumor initiation, progression,
metastasis, recurrence, and resistance to therapy. The origins of BCSCs remain …

Clinical developments of antitumor polymer therapeutics

S Parveen, F Arjmand, S Tabassum - RSC advances, 2019 - pubs.rsc.org
Polymer therapeutics encompasses polymer–drug conjugates that are nano-sized,
multicomponent constructs already in the clinic as antitumor compounds, either as single …